EHC Program Update: Draft Report Available for Comment; Publication of EHC Program Research and Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction

EHC Program Update: Draft Report Available for Comment; Publication of EHC Program Research

EHC Program Update: Draft Report Available for Comment; Publication of EHC Program Research

Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 11/29/2012 04:49 PM EST

The following have been posted to the EHC Program Web site:

The following have been posted to the EHC Program Web site:

Draft Report

The following draft report is available for comment until December 27, 2012:

Registries for Evaluating Patient Outcomes: A User's Guide: 3rd Edition. To access and comment, please visit:  http://www.effectivehealthcare.ahrq.gov/research-available-for-comment/comment-draft-reports/?pageaction=displayDraftCommentForm&topicid=420&productID=1337&ECem=121129. 

To access all EHC Program products that are currently available for comment, please visit: http://effectivehealthcare.ahrq.gov/research-available-for-comment/.

Journal Publication of EHC Program Study

The article, Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction, was just published in the Journal of the American Medical Association. To view the abstract, please visit: http://jama.jamanetwork.com/article.aspx?articleid=1456063.    

Effective Health Care Program
http://effectivehealthcare.ahrq.gov

EHC Program Update: Draft Report Available for Comment; Publication of EHC Program Research